Swan Winifred L 4
4 · NxStage Medical, Inc. · Filed Mar 12, 2018
Insider Transaction Report
Form 4
Swan Winifred L
SVP and General Counsel
Transactions
- Award
Restricted Stock Unit
2018-03-09+13,971→ 13,971 totalExercise: $0.00From: 2018-03-09Exp: 2020-03-09→ Common Stock (13,971 underlying) - Exercise/Conversion
Restricted Stock Unit
2018-03-09−4,657→ 9,314 totalExercise: $0.00From: 2018-03-09Exp: 2020-03-09→ Common Stock (4,657 underlying) - Exercise/Conversion
Common Stock
2018-03-09+4,657→ 14,427 total - Tax Payment
Common Stock
2018-03-09$24.37/sh−1,350$32,900→ 13,077 total
Footnotes (1)
- [F1]Award granted pursuant to the 2017 Performance Share Plan, vesting in 3 equal annual installments beginning March 9, 2018.